Induced pluripotent stem cells (iPSCs) are derived from adult cells, such as skin or blood cells, which have been “reprogrammed” back to a stem-cell-like state. This transformation grants them the ...
Market · GlobeNewswire Inc. The induced pluripotent stem cell (iPSC) market is experiencing robust growth, with a projected ...
SEATTLE, April 07, 2026 (GLOBE NEWSWIRE) -- Pluristyx, a leader in advanced induced pluripotent stem cell (iPSC)-based solutions, today announced expansion of its intellectual property portfolio with ...
Endogenous Retroviruses (ERVs), relics from ancient viral infections, form a significant part of vertebrate genomes, including humans, where they constitute ...
In April 2026, XellSmart officially launches its multicenter Phase II registrational clinical trial of the "Clinical-Grade, Allogeneic, Off-the-Shelf, iPSC-Derived, Dopaminergic Neural Progenitor Cell ...
Creative Biogene is proud to announce the launch of its innovative iPSC RNA reprogramming products, specifically designed to enhance the efficiency and safety of iPSC generation.
Cartherics Pty Ltd, a biotechnology company developing off‑the‑shelf immune cell therapies for high‑impact women’s diseases, including ovarian cancer and endometriosis, and Catalent, Inc., the leader ...
“One of the major advantages of Creative Biolabs,” the lead scientist explained during the interview, “is the versatility of ...
Over the past decade, improved understanding of the physiological and molecular pathology of the cardiovascular system has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results